Fig. 3From: Tofacitinib effectiveness in Blau syndrome: a case series of Chinese paediatric patientsPossible model of the activation of JAK and secretion of proinflammatory chemokines induced by the NOD2 mutation and their interference by tofacitinibBack to article page